Kailera Therapeutics Inc (KLRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||
| Net Income | -78,865 | N/A | -17,983 |
| Depreciation Amortization | 101 | N/A | 63 |
| Accounts payable and accrued liabilities | -495 | N/A | 645 |
| Other Working Capital | 7,466 | N/A | -984 |
| Other Operating Activity | 3,483 | 0 | 58 |
| Operating Cash Flow | $-68,310 | $N/A | $-18,201 |
| Cash Flows From Investing Activities | |||
| Purchase Of Investment | 22,849 | N/A | -54,440 |
| Investing Cash Flow | $22,849 | $N/A | $-54,440 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 57 | N/A | N/A |
| Other Financing Activity | -3,037 | 0 | 0 |
| Financing Cash Flow | $-2,980 | $N/A | $N/A |
| Beginning Cash Position | 161,028 | N/A | 175,178 |
| End Cash Position | 112,587 | N/A | 102,537 |
| Net Cash Flow | $-48,441 | $N/A | $-72,641 |
| Free Cash Flow | |||
| Operating Cash Flow | -68,310 | N/A | -18,201 |
| Free Cash Flow | -68,310 | 0 | -18,201 |